Pay in installments of $5.37 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 16 - Jul 21
For Your Every Summer RSVP, with Code: SUMMER15
Description
Daily Oral GLP 1 Receptor Agonist Orforglipron for Adults with Obesity New England Journal of Medicine GLP 1s AgelessRx Digital health company Ro launches GLP 1 insurance coverage checker to help patients navigate costs NBC 5 Dallas Fort Worth GLP 1 Support Balanced Meals All New High Protein Menu
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.2 ★★★★★
Based on 24 reviews
Sort
Product Reviews
★★★★★ 5
Great makeup remover pads - ILove them!!
These pads are wonderful. I have used them for many years and love them. They do not irritate my skin but are strong enough to remove eye makeup with no problems.,.ever. Am so glad I found some many years ago and will us for
The rest of my
Life.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 26, 2024
★★★★★ 5
They also make eye makeup removal pads
Great makeup remover
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on August 2, 2025
★★★★★ 1
Don’t buy
Didn’t take mascara off
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on August 7, 2025
★★★★★ 4
Good value
The sheets remove make well and are non-irritating. They are also reasonably priced.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 4, 2016
★★★★★ 5
Doesn’t burn my eyes.
Very gentle but powerful and compact…
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 12, 2024
recommand products
SOUL (Semaglutide cardiOvascular oUtcomes triaL) in individuals with
27.53
SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes
24.41
F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy
24.35
soul trial oral semaglutide cardiovascular outcomes results 2024 2025 Oral Semaglutide and Cardiovascular Outcomes in People
25.08
FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly
25.05